Correlation Between Franklin Biotechnology and Davis Financial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Franklin Biotechnology and Davis Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Biotechnology and Davis Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Biotechnology Discovery and Davis Financial Fund, you can compare the effects of market volatilities on Franklin Biotechnology and Davis Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Biotechnology with a short position of Davis Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Biotechnology and Davis Financial.

Diversification Opportunities for Franklin Biotechnology and Davis Financial

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Franklin and Davis is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and Davis Financial Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Davis Financial and Franklin Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Biotechnology Discovery are associated (or correlated) with Davis Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Davis Financial has no effect on the direction of Franklin Biotechnology i.e., Franklin Biotechnology and Davis Financial go up and down completely randomly.

Pair Corralation between Franklin Biotechnology and Davis Financial

Assuming the 90 days horizon Franklin Biotechnology Discovery is expected to under-perform the Davis Financial. In addition to that, Franklin Biotechnology is 1.75 times more volatile than Davis Financial Fund. It trades about -0.29 of its total potential returns per unit of risk. Davis Financial Fund is currently generating about -0.31 per unit of volatility. If you would invest  7,050  in Davis Financial Fund on September 27, 2024 and sell it today you would lose (585.00) from holding Davis Financial Fund or give up 8.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Franklin Biotechnology Discove  vs.  Davis Financial Fund

 Performance 
       Timeline  
Franklin Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Davis Financial 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Davis Financial Fund are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Davis Financial is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology and Davis Financial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Franklin Biotechnology and Davis Financial

The main advantage of trading using opposite Franklin Biotechnology and Davis Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Biotechnology position performs unexpectedly, Davis Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Davis Financial will offset losses from the drop in Davis Financial's long position.
The idea behind Franklin Biotechnology Discovery and Davis Financial Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance